Details of the Drug

General Information of Drug (ID: DMJLFAK)

Drug Name

TAK-062

Synonyms

zamaglutenase

Indication

Disease Entry	ICD 11	Status	REF
Coeliac disease	DA95	Phase 2	[1]
------------------------------------------------------------------------------------

Drug Type

Enzyme replacement

Cross-matching ID

References

1	ClinicalTrials.gov (NCT05353985) A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of TAK-062 for the Treatment of Active Celiac Disease in Subjects Attempting a Gluten-Free Diet. U.S.National Institutes of Health.